Ganciclovir

Administration

• Type: Antiviral
• Routes of Administration: IV, PO
• Common Trade Names: Cytovene

Adult Dosing

• CMV prophylaxis, solid organ transplant
  • IV route: 5 mg/kg IV q12h x7-14 days, then 5 mg/kg IV q24h or 6 mg/kg IV 5x/wk
  • PO route: 1000 mg PO tid, give w/ food

• CMV prophylaxis, HIV-assoc.
  • IV route: 5 mg/kg IV 5-7x/wk; Info: not 1st-line agent
  • PO route: 1000 mg PO tid; Info: not 1st-line agent; give w/ food

• CMV retinitis, immunocompromised pts
  • Induction tx: 5 mg/kg IV q12h x14-21 days; Info: not 1st-line agent
  • Maintenance tx, IV route: 5 mg/kg IV 5-7x/wk; Alt: 6 mg/kg IV 5x/wk; Info: not 1st-line agent
  • Maintenance tx, PO route: 1000 mg PO tid; Alt: 500 mg PO q3h while awake (6 doses/day); Info: not 1st-line agent; give w/ food

Special Populations

• Pregnancy Rating:
• Lactation risk:

Renal Dosing

• IV route, induction tx: CrCl 50-69: 2.5 mg/kg q12h; CrCl 25-49: 2.5 mg/kg q24h; CrCl 10-24: 1.25 mg/kg q24h; CrCl <10: 1.25 mg/kg 3x/wk; HD: give dose after dialysis, no supplement
• IV route, maintenance tx: CrCl 50-69: 2.5 mg/kg q24h; CrCl 25-49: 1.25 mg/kg q24h; CrCl 10-24: 0.625 mg/kg q24h; CrCl <10: 0.625 mg/kg 3x/wk; HD: give dose after dialysis, no supplement
• PO route: CrCl 50-69: 1500 mg/day divided qd-tid; CrCl 25-49: 1000 mg/day divided qd-bid; CrCl 10-24: 500 mg qd; CrCl <10: 500 mg 3x/wk; HD: give dose after dialysis, no supplement

Contraindications

• Allergy to class/drug
• hypersens. to acyclovir
• ANC <500
• Plt <25,000

Adverse Reactions

Serious

• thrombocytopenia
• neutropenia
• pancytopenia
• sepsis
• nephrotoxicity
• seizures
• retinal detachment
• HTN
• pancreatitis

Common

• diarrhea
• fever
• leukopenia
• anorexia
• vomiting

Pharmacology

• Half-life: 3hr
• Metabolism: CYP450
• Excretion: Urine

Mechanism of Action

Inhibits DNA polymerase and incorporates into viral DNA

References

Epocrates, UpToDate